Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Taysha Gene Therapies Inc
About TSHA
Taysha Gene Therapies Inc is a clinical-stage biotechnology company, which is focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. The Company’s lead clinical program, TSHA-102, is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder. The Company is evaluating TSHA-102 in the REVEALPhase I/II adolescent and adult clinical trial, which is a first-in-human, open-label, randomized, dose escalation and dose-expansion, multicenter study evaluating the safety and preliminary efficacy of TSHA-102 in female patients aged 12-years and older with Rett syndrome. It has acquired a worldwide right to a clinical-stage, intrathecally dosed AAV9 gene therapy program, TSHA-120, for the treatment of giant axonal neuropathy (GAN). TSHA-105 is a gene replacement therapy in development for the treatment of SLC13A5 deficiency, a rare autosomal recessive epileptic encephalopathy.
Find out what a historical investment in Taysha Gene Therapies Inc would be worth today using our TSHA stock calculator.
Market Capitalisation
$1.49B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
3.14M
High today
$5.54
Low today
$5.17
Open price
$5.25
52-week high
$7.30
52-week low
$2.25
Ready to start your investing journey with Stake?
Open an accountHow do I buy TSHA shares in Australia?
Buying TSHA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Taysha Gene Therapies Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in TSHA
What is the ticker symbol of Taysha Gene Therapies Inc?
The ticker symbol for Taysha Gene Therapies Inc is TSHA.
How much is one share of TSHA?
One share of TSHA is valued at $5.49 as of 20 May 2026.
What is the market capitalisation of Taysha Gene Therapies Inc TSHA?
As of 20 May 2026 Taysha Gene Therapies Inc has a market cap of $1.49B.
What is the 52-week high for Taysha Gene Therapies Inc stock?
The Taysha Gene Therapies Inc 52-week high stock price is $7.30.
What is the 52-week low for Taysha Gene Therapies Inc stock?
The Taysha Gene Therapies Inc 52-week low stock price is $2.25.
Can I buy TSHA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TSHA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TSHA on Stake
- Buy TSHA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of TSHA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
TSHA related stocks